FORGET decorating the Christmas tree and wrapping presents, this year there’s a new festive stress to contend with… for the ...

On today's Morning Brief, Yahoo Finance executive editor Brian Sozzi helps investors start their trading day off right by covering the top market headlines before the opening bell on December 23, 2025 ...

IAEA assists countries in minimising unnecessary radiation exposure while ensuring treatments deliver required dose.

The Food and Drug Administration on Monday approved a pill version of Wegovy, Novo Nordisk’s blockbuster weight loss drug.

The Food and Drug Administration on Monday approved a pill version of the weight-loss injectable drug Wegovy, offering ...

The Wegovy pill is one of two oral GLP-1 drugs expected to hit the market in the next few months; the other, from Lilly, is called orforglipron – until it receives a brand name – and is expected to be ...

A pill version of the popular GLP-1 weight-loss drug Wegovy has been greenlit for use in the U.S. Here’s what that means for ...

This new pill contains the same active ingredient as injectable Wegovy and Ozempic, semaglutide. It is the first GLP-1 pill ...

A triple dose of Novo Nordisk's GLP-1 agonist Wegovy has shown improved activity on weight loss in an obesity trial, as the drugmaker tries to fend off a marketplace challenge from Eli Lilly. A 7.2mg ...

AQVESME is the only FDA-approved medicine for anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemiaMarketed under AQVESME brand name in the U.S. for thalassemia ...

U.S. regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.

The best time to take berberine may be with or just before meals when using it for weight loss and blood sugar control.